Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid crawled date : 2020 - 12 - 17 save search
Novant Health administers its first COVID-19 vaccine
Published: 2020-12-17 (Crawled : 21:12) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -1.49%
H: 3.13%
C: -0.07%
covid vaccine covid-19 health
Vir Biotechnology and GSK Announce Start of NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19
Published: 2020-12-17 (Crawled : 21:05) - globenewswire.com
VIR | $8.18 -0.85% 270K
|
Health Technology
|
| O: 0.83%
H: 1.43%
C: -6.46%
covid biotech trial
Envirotainer Deploys Vuzix Smart Glasses-Based Remote Training to Support its Active Temperature-Controlled Containers for COVID-19 Vaccine and Pharmaceutical Shipments
Published: 2020-12-17 (Crawled : 21:01) - biospace.com/
VUZI | $1.33 9.02% 540K
|
Electronic Technology
|
| O: 0.63%
H: 10.8%
C: 4.23%
vaccine covid glass train
Silver Lake Center, Affiliated with Genesis HealthCare, Among the First Long-Term Care Facilities in the U.S. to Administer COVID-19 Vaccine to Frontline Healthcare Workers
Published: 2020-12-17 (Crawled : 19:01) - globenewswire.com
GEN | $20.4 0.15% 1.4M
|
Health Services
|
| O: 1.73%
H: 9.43%
C: 1.89%
vaccine covid
Eloxx Pharmaceuticals Provides Update on the Impact of Novel Coronavirus (COVID-19) on Phase 2 Clinical Trials in Cystic Fibrosis
Published: 2020-03-25 (Crawled : 18:16) - globenewswire.com
ELOX | $0.9625 93K
|
Health Technology
|
| O: -4.0%
H: 0.0%
C: -12.5%
covid trial phase 2 fibrosis cystic fibrosis
Enrollment in Phase 2 Clinical Trial in Cystic Fibrosis Has Been Resumed in Israel and Europe After Being Paused Temporarily in Response to the COVID-19 Pandemic
Published: 2020-06-17 (Crawled : 18:16) - globenewswire.com
ELOX | $0.9625 93K
|
Health Technology
|
| O: 14.75%
H: 14.86%
C: 0.86%
covid israel trial phase 2 europe fibrosis enroll cystic fibrosis
Enrollment in the U.S. Phase 2 Clinical Trial in Cystic Fibrosis Has Resumed After Being Paused in Response to the COVID-19 Pandemic
Published: 2020-08-12 (Crawled : 18:16) - globenewswire.com
ELOX | $0.9625 93K
|
Health Technology
|
| O: 0.0%
H: 11.65%
C: 8.09%
covid trial phase 2 fibrosis enroll cystic fibrosis
Pressure BioSciences PCT Platform at Forefront in Generating Pivotal Findings by Diverse COVID-19 Research Teams in USA, China, and Europe
Published: 2020-12-17 (Crawled : 18:01) - biospace.com/
PBIO | $0.25 43K
|
Health Technology
|
| O: 0.18%
H: 7.01%
C: -15.13%
china covid research europe
Quest Diagnostics and The Commons Project to Deliver Convenient Access to Lab Data -- Including COVID-19 Test Results -- Through the CommonHealth App
Published: 2020-12-17 (Crawled : 15:00) - biospace.com/
DGX | $126.07 -0.72% 220K
|
Health Services
|
| O: -0.79%
H: 1.8%
C: 0.58%
results covid test liver diagnostic
Aldeyra Therapeutics Announces Initiation of Phase 2 Clinical Trials of ADX-629, a First-in-Class Orally Administered RASP Inhibitor, for the Treatment of COVID-19, Atopic Asthma, and Psoriasis
Published: 2020-12-17 (Crawled : 15:00) - biospace.com/
ALDX 4 | $4.01 1.01% 210K
|
Health Technology
|
| O: 2.88%
H: 1.6%
C: 0.4%
covid trial phase 2 psoriasis
Traffic on Major U.S. Toll Road Systems Achieves Strong Recovery Toward Pre-COVID-19 Levels
Published: 2020-12-17 (Crawled : 14:01) - globenewswire.com
CNDT 4 | $3.06 1.33% 210K
|
Commercial Services
|
| O: 0.67%
H: 0.19%
C: -3.43%
covid covid-19
COVID-19’s Impact on the Insurance Industry Will Continue Well into 2021
Published: 2020-12-17 (Crawled : 13:04) - globenewswire.com
TRU | News | $68.34 -1.85% 930K
|
Technology Services
|
| O: 0.82%
H: 0.64%
C: 0.34%
covid insurance covid-19
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 VaccineAdvance purchase agreement signed for NVX-CoV2373, Novavax’ adjuvanted protein vaccine candidate
Published: 2020-12-17 (Crawled : 06:00) - biospace.com/
NVAX | $3.92 0.77% 1.3M
|
Health Technology
|
| O: 2.98%
H: 6.57%
C: 5.84%
vaccine covid nvx-cov2373
Future Uncertainty Hangs Heavy in Cigna COVID-19 Study
Published: 2020-12-17 (Crawled : 05:10) - prnewswire.com
CI | $347.73 0.48% 820K
|
Health Services
|
| O: 0.45%
H: 1.01%
C: -0.33%
covid covid-19
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine
Published: 2020-12-17 (Crawled : 01:00) - globenewswire.com
NVAX | $3.92 0.77% 1.3M
|
Health Technology
|
| O: 2.98%
H: 6.57%
C: 5.84%
vaccine covid covid-19
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.